Metropolis Healthcare Financials

METROPOLIS   2,062  46.70  2.32%   
We recommend to make use of Metropolis Healthcare Limited fundamental analysis to see if markets are presently undervaluing or overvaluing the entity. Strictly speaking, this technique allows you to check out available financial ratios of Metropolis Healthcare as well as the relationship between them. We were able to break down and interpolate twenty-eight available fundamentals for Metropolis Healthcare, which can be compared to its peers in the industry. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Metropolis Healthcare to be traded at 2474.22 in 90 days. Key indicators impacting Metropolis Healthcare's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income1.9 B2.1 B
Significantly Down
Slightly volatile
  
Understanding current and past Metropolis Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Metropolis Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Metropolis Healthcare's assets may result in an increase in income on the income statement.

Metropolis Healthcare Stock Summary

Metropolis Healthcare competes with Praxis Home, Tamilnadu Telecommunicatio, OnMobile Global, Krebs Biochemicals, and V Mart. Metropolis Healthcare is entity of India. It is traded as Stock on NSE exchange.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentIndia Stock View All
ExchangeNational Stock Exchange of India
ISININE112L01020
Business AddressEast Wing, Plot-254
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.metropolisindia.com
Phone91 8422 801 801
You should never invest in Metropolis Healthcare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Metropolis Stock, because this is throwing your money away. Analyzing the key information contained in Metropolis Healthcare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Metropolis Healthcare Key Financial Ratios

Metropolis Healthcare's financial ratios allow both analysts and investors to convert raw data from Metropolis Healthcare's financial statements into concise, actionable information that can be used to evaluate the performance of Metropolis Healthcare over time and compare it to other companies across industries.

Metropolis Healthcare Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets7.5B10.0B15.3B15.0B15.6B9.2B
Other Current Liab510.8M371.6M337.5M345.5M368.0M362.0M
Other Liab118.2M134.6M992.8M918.1M1.1B1.1B
Net Tangible Assets4.0B5.8B702.2M1.6B1.4B2.3B
Net Debt(404.7M)(2.7B)3.1B2.0B1.3B1.3B
Retained Earnings3.7B5.1B6.8B7.8B9.2B4.8B
Accounts Payable850.3M1.1B901.3M940.8M994.4M681.4M
Cash1.1B3.9B659.8M688.3M712.2M899.5M
Other Assets534.8M509.9M707.1M540.0M621.0M361.9M
Net Receivables1.4B1.2B1.4B1.3B1.3B1.2B
Good Will785.5M903.5M902.5M4.5B5.2B5.5B
Inventory244.0M405.5M511.1M445.9M386.9M309.1M
Other Current Assets1.7B245.0M259.3M538.9M1.5B936.7M
Total Liab2.3B3.0B6.4B5.1B4.6B2.8B
Short Long Term Debt5.3M177.4M351K0.0998.7M504.4M
Total Current Assets4.0B6.1B3.9B3.0B3.2B3.7B
Short Term Debt209.2M104.4M1.4B1.1B439.2M372.2M
Intangible Assets281.6M345.9M3.6B3.7B3.9B4.1B
Common Stock101.3M102.2M102.3M102.4M102.5M109.5M
Long Term Debt Total457.8M789.3M2.4B1.5B1.8B1.9B
Capital Surpluse1.2B1.5B1.6B1.6B1.8B1.2B
Net Invested Capital5.2B7.1B11.4B10.7B11.0B8.5B
Net Working Capital2.3B4.0B915.7M377.6M699.6M1.4B

Metropolis Healthcare Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense83.4M77.8M197.4M268.0M278.4M292.3M
Total Revenue8.6B10.0B12.3B11.5B12.1B8.7B
Gross Profit6.4B7.4B9.4B8.9B5.8B6.2B
Operating Income1.8B2.5B2.8B2.1B2.1B1.9B
Ebit1.8B2.6B3.2B2.2B2.0B2.0B
Research Development80.9M68.3M89.1M87.4M135.8M78.9M
Ebitda2.2B3.0B3.8B3.1B3.0B2.4B
Cost Of Revenue2.1B2.6B2.9B2.6B6.3B6.6B
Income Before Tax1.7B2.4B2.9B1.9B1.7B1.9B
Net Income1.3B1.8B2.1B1.4B1.3B1.3B
Income Tax Expense411.8M609.7M786.7M441.1M462.3M548.3M
Minority Interest16.6M14.6M(5.0M)(5.1M)(6.4M)(6.1M)
Tax Provision411.8M609.7M786.7M441.1M462.3M591.8M
Interest Income7.0M77.8M197.4M268.0M32.6M31.0M
Net Interest Income(67.5M)(77.8M)(197.4M)(268.0M)(225.4M)(214.1M)

Metropolis Healthcare Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory17.0M(161.5M)(79.4M)65.2M59.0M61.9M
Investments(606.4M)848.5M(800.4M)467.9M(894.1M)(849.4M)
Change In Cash558.0M2.8B(3.2B)28.5M(62.1M)(59.0M)
Net Borrowings(310.7M)(179.8M)2.2B(2.2B)(2.0B)(1.9B)
Free Cash Flow1.8B2.2B2.2B1.9B2.0B1.4B
Depreciation392.7M459.4M632.2M892.2M944.7M991.9M
Other Non Cash Items24.5M(15.2M)71.7M210.9M406.2M426.5M
Dividends Paid401.4M408.9M409.4M409.7M205.0M392.1M
Capital Expenditures362.1M282.7M306.6M526.3M637.6M331.9M
Net Income1.7B2.4B2.9B1.9B1.3B1.8B
End Period Cash Flow1.1B3.9B659.8M688.3M626.2M881.8M
Change To Netincome204.4M353.0M(77.3M)78.8M90.6M67.4M

Metropolis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Metropolis Healthcare's current stock value. Our valuation model uses many indicators to compare Metropolis Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Metropolis Healthcare competition to find correlations between indicators driving Metropolis Healthcare's intrinsic value. More Info.
Metropolis Healthcare Limited is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.65  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Metropolis Healthcare Limited is roughly  1.54 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Metropolis Healthcare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Metropolis Healthcare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Metropolis Healthcare Systematic Risk

Metropolis Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Metropolis Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Metropolis Healthcare correlated with the market. If Beta is less than 0 Metropolis Healthcare generally moves in the opposite direction as compared to the market. If Metropolis Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Metropolis Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Metropolis Healthcare is generally in the same direction as the market. If Beta > 1 Metropolis Healthcare moves generally in the same direction as, but more than the movement of the benchmark.

Metropolis Healthcare Limited Total Assets Over Time

Metropolis Healthcare Thematic Clasifications

Metropolis Healthcare Limited is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
Health ManagementView
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas

Metropolis Healthcare November 23, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Metropolis Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Metropolis Healthcare Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Metropolis Healthcare Limited based on widely used predictive technical indicators. In general, we focus on analyzing Metropolis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Metropolis Healthcare's daily price indicators and compare them against related drivers.

Other Information on Investing in Metropolis Stock

Metropolis Healthcare financial ratios help investors to determine whether Metropolis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Metropolis with respect to the benefits of owning Metropolis Healthcare security.